Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 110 of 110 entries
View as:

Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT04354038 Org: User:
Start: 01/07/20 End: 12/31/26 Due: 12/31/27

Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy

Phase: N/A Priority: Normal
NCT ID: NCT03089476 Org: User:
Start: 09/30/17 End: 07/30/18 Due: 07/30/19

Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06270576 Org: User:
Start: 04/30/24 End: 06/30/28 Due: 06/30/29

The Role of Laryngopharyngeal Reflux in IPF

Phase: N/A Priority: Normal
NCT ID: NCT03418350 Org: User:
Start: 08/01/18 End: 12/31/26 Due: 12/31/27

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04598919 Org: User:
Start: 11/12/20 End: 06/30/25 Due: 06/30/26

Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02169752 Org: User:
Start: 09/30/12 End: 05/25/17 Due: 05/25/18

Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)

Phase: N/A Priority: Normal
NCT ID: NCT02604693 Org: User:
Start: 12/14/14 End: 12/31/20 Due: 12/31/21

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

Phase: N/A Priority: Normal
NCT ID: NCT06262282 Org: User:
Start: 02/05/24 End: 12/31/28 Due: 12/31/29

Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

Phase: N/A Priority: Normal
NCT ID: NCT03010436 Org: User:
Start: 04/15/17 End: 12/31/21 Due: 12/31/22

Pulmonary Fibrosis Contact Registry

Phase: N/A Priority: Normal
NCT ID: NCT01935726 Org: User:
Start: 08/31/13 End: 03/10/19 Due: 03/10/20